H200s in China, Apple Blocks Vibe Coding, Peptide Debates | Andy Fang, Matt Jayson, Dr. Cameron Sepah, Chris Gadek, Chris Hladczuk, Georgios Konstantopoulos, Matt Huang
HomeTBPN › Episode

H200s in China, Apple Blocks Vibe Coding, Peptide Debates | Andy Fang, Matt Jayson, Dr. Cameron Sepah, Chris Gadek, Chris Hladczuk, Georgios Konstantopoulos, Matt Huang

3:07:12 Mar 18, 2026
About this episode
Sign up for TBPN’s daily newsletter at TBPN.com(05:54) - H200s Are Going to China (18:27) - 𝕏 Timeline Reactions (27:33) - Apple Cracks Down on Vibe Coding Apps (37:36) - Peptide Debate (46:17) - 𝕏 Timeline Reactions (54:50) - Private Credit Meets the AI Shift (01:05:44) - Andy Fang, co-founder and head of consumer engineering at DoorDash, discusses the company's recent acquisition of Metis, an applied AI research lab, to enhance AI integration into their services. He highlights the potential of AI to improve customer experiences by addressing decision paralysis through agentic commerce, and to assist restaurants in optimizing operations, such as pricing and promotions. Fang also emphasizes the importance of creating seamless, beneficial AI-driven experiences without overtly branding them as AI features. (01:25:05) - Matt Jayson, founder and CEO of Multiply, discusses his company's innovative approach as the first hybrid AI media agency, combining AI agents with human expertise to create self-learning ads that adapt based on customer feedback. He highlights their recent emergence from stealth mode with a $9.5 million funding round and emphasizes the need for modernized advertising strategies in the B2B sector, noting that traditional ads become stale quickly. By integrating AI with human media buying, Multiply aims to revolutionize advertising effectiveness and efficiency. (01:34:12) - Dr. Cameron Sepah, a licensed clinical psychologist and former assistant clinical professor of psychiatry at UCSF School of Medicine, is the founder and CEO of Maximus, a company specializing in men's health and hormone optimization. In the conversation, he discusses the concept of performance medicine, emphasizing the use of FDA-approved treatments like testosterone, GLP-1 agonists, and growth hormone peptides to enhance health and performance. Dr. Sepah also highlights the importance of personalized medicine, advocating for tailored protocols that address individual health needs beyond traditional healthcare models. (02:06:19) - Chris Gadek, CEO of AdQuick, discusses how the company is revolutionizing out-of-home (OOH) advertising by integrating technology to streamline planning, buying, and measurement processes. He highlights AdQuick's recent partnership with OUTFRONT Media, a major player in the OOH space, to enhance campaign execution and measurement across various formats. Gadek also emphasizes the importance of proving the effectiveness of OOH advertising through advanced analytics and measurement tools. (02:17:05) - Chris Hladczuk, co-founder and CEO of Hanover Park, an AI-native fund administration platform, discusses how his company streamlines financial operations for investment firms by replacing manual processes—referred to as "human duct tape"—with AI-driven solutions. He highlights the platform's ability to provide rea
Select an episode
0:00 0:00